Six Months of Parathyroid Hormone (1–84) Administered ConcurrentlyVersusSequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial | Zendy

Anne L. Schafer | Zendy; Deborah E. Sellmeyer | Zendy; Lisa Palermo | Zendy; Jean Hietpas | Zendy; Richard Eastell | Zendy; Dolores Shoback | Zendy; Dennis M. Black | Zendy

Open Access

Six Months of Parathyroid Hormone (1–84) Administered ConcurrentlyVersusSequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial

Author(s) -

Anne L. Schafer,

Deborah E. Sellmeyer,

Lisa Palermo,

Jean Hietpas,

Richard Eastell,

Dolores Shoback,

Dennis M. Black

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-1844

Subject(s) - medicine , bone mineral , parathyroid hormone , urology , osteoporosis , anabolism , randomized controlled trial , confidence interval , bone remodeling , bisphosphonate , endocrinology , calcium

PTH therapy improves bone mineral density (BMD) and decreases fractures in postmenopausal osteoporosis, but cost and the burden of daily injections limit its use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research